D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
PUT
e.l.f. Beauty
ELF
$5.69B
| $21M | 0.02% |
107,300
+15,400
| +17% | +$2.74M |
|
827
CenterPoint Energy
CNP
$25.2B
| $21M | 0.02% |
738,182
+244,766
| +50% | +$6.86M |
|
|
ODP
828
DELISTED
ODP
ODP
| $20.9M | 0.02% |
393,929
-126,844
| -24% | -$6.63M |
|
829
PUT
Wingstop
WING
$2.84B
| $20.4M | 0.02% |
55,800
+15,800
| +40% | +$4.92M |
|
|
ATSG
830
DELISTED
Air Transport Services Group
ATSG
| $20.4M | 0.02% |
1,485,493
+148,354
| +11% | +$2.14M |
|
831
Valero Energy
VLO
$119B
| $20.4M | 0.02% |
119,369
-50,357
| -30% | -$7.21M |
|
832
Union Pacific
UNP
$166B
| $20.4M | 0.02% |
82,773
-33,379
| -29% | -$8.21M |
|
833
PUT
Lincoln National
LNC
$8.08B
| $20.3M | 0.02% |
637,300
+135,100
| +27% | +$3.73M |
|
834
RLI Corp
RLI
$5.45B
| $20.3M | 0.02% |
274,030
+25,400
| +10% | +$1.81M |
|
835
Henry Schein
HSIC
$9.46B
| $20.3M | 0.02% |
268,913
-267,150
| -50% | -$20M |
|
836
Vodafone
VOD
$39.2B
| $20.3M | 0.02% |
2,278,227
+1,693,420
| +290% | +$14.7M |
|
837
PUT
Royal Bank of Canada
RY
$281B
| $20.2M | 0.02% |
200,000
-415,000
| -67% | -$41M |
|
838
Fate Therapeutics
FATE
$303M
| $20M | 0.02% |
2,730,966
-851,013
| -24% | -$5.27M |
|
839
Neurocrine Biosciences
NBIX
$14.9B
| $20M | 0.02% |
145,280
+69,278
| +91% | +$9.46M |
|
840
Adient
ADNT
$1.36B
| $20M | 0.02% |
608,621
+358,829
| +144% | +$12.2M |
|
841
Hexcel
HXL
$6.67B
| $20M | 0.02% |
274,260
+144,831
| +112% | +$10.4M |
|
842
CALL
MongoDB
MDB
$30.9B
| $19.9M | 0.02% |
55,600
-161,800
| -74% | -$66.1M |
|
|
B
843
PUT
Barrick Mining
B
$71.3B
| $19.9M | 0.02% |
1,198,300
-34,600
| -3% | -$541K |
|
844
CALL
XPO
XPO
$20.4B
| $19.9M | 0.02% |
163,100
+159,300
| +4,192% | +$17.1M |
|
845
Huntsman Corp
HUN
$1.59B
| $19.9M | 0.02% |
764,387
+174,587
| +30% | +$4.33M |
|
846
Braze
BRZE
$2.77B
| $19.9M | 0.02% |
448,428
+10,979
| +3% | +$593K |
|
847
CALL
Snap
SNAP
$9.35B
| $19.8M | 0.02% |
1,722,500
+527,500
| +44% | +$7.07M |
|
848
Veeco
VECO
$2.61B
| $19.8M | 0.02% |
562,110
-323,055
| -36% | -$10.8M |
|
849
Diodes
DIOD
$4.25B
| $19.6M | 0.02% |
278,637
+180,925
| +185% | +$12.6M |
|
|
MRSH
850
Marsh
MRSH
$83.5B
| $19.6M | 0.02% |
95,326
-8,664
| -8% | -$1.73M |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.